Ross Macdonald

Chief Executive, Managing Director / Cynata Therapeutics

Dr Ross Macdonald has over 32 years of experience in pharmaceutical and biotechnology businesses.

He was vice president of business development at Sinclair Pharmaceuticals (now Sinclair Pharma), a UK-based specialty pharmaceuticals company; and vice president of corporate development at Stiefel Laboratories, the largest independent dermatology company in the world and acquired by GlaxoSmithKline in 2009. He was also chief executive of Living Cell Technologies, vice president of business development at Connetics Corporation, and vice president of research & development at FH Faulding & Co.

Lists and Charts

Roles

2013

Chief Executive, Managing Director

Cynata Therapeutics

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
163^rd	Pantoro	87.1%	-8%
164^th	Service Stream	87.04%	-5.17%
165^th	Cynata Therapeutics	86.55%	-28.36%
166^th	Tribune Resources	86.3%	-0.4%
167^th	James Bay Minerals	86.18%	0%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

NEW ROLE: Chief Executive, Managing Director, Cynata Therapeutics

03 Nov 2020

Article Timeline

Related Information

Access to our data for Ross Macdonald is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Ross Macdonald is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.